How AI is Unlocking Smarter Clinical Trial ProtocolsNews DeskJune 8, 20260 Artificial intelligence (AI) is transforming how medicines are discovered, but clinical trials are still governed by a structure that has…
AI in Drug Discovery: Surveying the Breadth of the ChallengesNews DeskJune 4, 20260 The biotech industry is in the midst of an artificial intelligence (AI) investment surge, with companies pouring billions into the…
Why Patient Engagement Is Clinical Trials’ Next Strategic FrontierNews DeskMay 20, 20260 The clinical trial industry spent the better part of the last decade solving a proximity problem. If patients couldn’t —…
What Comes After Pluvicto? A New and Distinct Prostate Cancer Patient Subpopulation Is Taking ShapeNews DeskMay 18, 20260 Treatment decisions are more than selecting which therapy, but also when to use it. This sequencing of therapies in advanced…
Our Aging Population is Forcing a Rethink of How We Design & Package MedicinesNews DeskMay 14, 20260 For biopharma companies, designing therapies with elderly patients in mind is no longer a nice-to-have — it’s a clear business…
The Changing Landscape of New Approach MethodologiesNews DeskMay 13, 20260 The past year has marked a turning point for New Approach Methodologies (NAMs) in preclinical drug development. No longer experimental…